55 related articles for article (PubMed ID: 27044383)
21. Detection and treatment of minimal residual disease in high-risk neuroblastoma.
Reynolds CP
Pediatr Transplant; 2004 Jun; 8 Suppl 5():56-66. PubMed ID: 15125707
[TBL] [Abstract][Full Text] [Related]
22. The role of age in neuroblastoma risk stratification: the German, Italian, and children's oncology group perspectives.
London WB; Boni L; Simon T; Berthold F; Twist C; Schmidt ML; Castleberry RP; Matthay KK; Cohn SL; De Bernardi B
Cancer Lett; 2005 Oct; 228(1-2):257-66. PubMed ID: 16024170
[TBL] [Abstract][Full Text] [Related]
23. gamma-Interferon increases metaiodobenzylguanidine incorporation and retention in human neuroblastoma cells.
Montaldo PG; Carbone R; Ponzoni M; Cornaglia-Ferraris P
Cancer Res; 1992 Sep; 52(18):4960-4. PubMed ID: 1325288
[TBL] [Abstract][Full Text] [Related]
24. [(131)I] and [(125)I] metaiodobenzylguanidine therapy in macroscopic and microscopic tumors: a comparative study in SK-N-SH human neuroblastoma and PC12 rat pheochromocytoma xenografts.
Rutgers M; Buitenhuis CK; van der Valk MA; Hoefnagel CA; Voûte PA; Smets LA
Int J Cancer; 2000 Dec; 90(6):312-25. PubMed ID: 11180134
[TBL] [Abstract][Full Text] [Related]
25. Neuroblastoma-derived secretory protein messenger RNA levels correlate with high-risk neuroblastoma.
Vasudevan SA; Russell HV; Okcu MF; Burlingame SM; Liu ZJ; Yang J; Nuchtern JG
J Pediatr Surg; 2007 Jan; 42(1):148-52. PubMed ID: 17208556
[TBL] [Abstract][Full Text] [Related]
26. [131I meta-iodobenzylguanidine in combination with hyperbaric oxygen therapy in the treatment of prognostically high-risk forms of neuroblastoma].
Stanková J; Kavan P; Krízová H; Hermanská E; Dosel P; Sázel M
Cas Lek Cesk; 2001 Jan; 140(1):13-7. PubMed ID: 11242978
[TBL] [Abstract][Full Text] [Related]
27. Upfront treatment of high-risk neuroblastoma with a combination of 131I-MIBG and topotecan.
Kraal KC; Tytgat GA; van Eck-Smit BL; Kam B; Caron HN; van Noesel M
Pediatr Blood Cancer; 2015 Nov; 62(11):1886-91. PubMed ID: 25981988
[TBL] [Abstract][Full Text] [Related]
28. International Society of Pediatric Oncology, Italian Society of Radiology and Nuclear Medicine, Italian Society of Biology and Nuclear Medicine, and Associazione Genitori Oncologia Pediatrica. IVth International Workshop in Pediatric Oncology: "The role of MIBG in therapy, diagnosis, and monitoring of neuroblastoma". Rome, Italy, September 22 and 23, 1986. Proceedings.
Med Pediatr Oncol; 1987; 15(4):157-228. PubMed ID: 3657702
[No Abstract] [Full Text] [Related]
29. Biology of metaiodobenzylguanidine interactions with human neuroblastoma cells.
Iavarone A; Lasorella A; Servidei T; Riccardi R; Troncone L; Mastrangelo R
J Nucl Biol Med (1991); 1991; 35(4):186-90. PubMed ID: 1823815
[TBL] [Abstract][Full Text] [Related]
30. Results of the First Prospective Multi-institutional Treatment Study in Children With Bilateral Wilms Tumor (AREN0534) A Report From the Children's Oncology Group: Erratum.
Ann Surg; 2018 Mar; 267(3):e64. PubMed ID: 29401136
[No Abstract] [Full Text] [Related]
31. Erratum to "Benefit of delayed primary excision in rhabdomyosarcoma: A report from the Children's Oncology Group".
Cancer; 2023 Mar; 129(6):970. PubMed ID: 36718079
[No Abstract] [Full Text] [Related]
32. Erratum: single-cell protein secretomic signatures as potential correlates to tumor cell lineage evolution and cell-cell interaction.
Kwak M; Mu L; Lu Y; Chen JJ; Wu Y; Brower K; Fan R
Front Oncol; 2013; 3():78. PubMed ID: 23579430
[No Abstract] [Full Text] [Related]
33. Evaluation of Norepinephrine Transporter Expression and Metaiodobenzylguanidine Avidity in Neuroblastoma: A Report from the Children's Oncology Group.
Dubois SG; Geier E; Batra V; Yee SW; Neuhaus J; Segal M; Martinez D; Pawel B; Yanik G; Naranjo A; London WB; Kreissman S; Baker D; Attiyeh E; Hogarty MD; Maris JM; Giacomini K; Matthay KK
Int J Mol Imaging; 2012; 2012():250834. PubMed ID: 23050139
[TBL] [Abstract][Full Text] [Related]
34. 131I-MIBG followed by consolidation with busulfan, melphalan and autologous stem cell transplantation for refractory neuroblastoma.
French S; DuBois SG; Horn B; Granger M; Hawkins R; Pass A; Plummer E; Matthay K
Pediatr Blood Cancer; 2013 May; 60(5):879-84. PubMed ID: 23024113
[TBL] [Abstract][Full Text] [Related]
35. [Radio iodized metaiodobenzylguanidine (MIBG) in the treatment of neuroblastoma: modalities and indications].
Défachelles AS; Cougnenc O; Carpentier P
Bull Cancer; 2011 May; 98(5):559-69. PubMed ID: 21609890
[TBL] [Abstract][Full Text] [Related]
36. Radiolabeled metaiodobenzylguanidine for imaging and therapy of neuroblastoma.
Taggart D; Dubois S; Matthay KK
Q J Nucl Med Mol Imaging; 2008 Dec; 52(4):403-18. PubMed ID: 19088694
[TBL] [Abstract][Full Text] [Related]
37. Erratum to: Vesicular monoamine transporter protein expression correlates with clinical features, tumor biology, and MIBG avidity in neuroblastoma: a report from the Children's Oncology Group.
Temple W; Mendelsohn L; Kim GE; Nekritz E; Gustafson WC; Lin L; Giacomini K; Naranjo A; Van Ryn C; Parisi MT; Shulkin BL; Yanik GA; Kreissman SG; Hogarty M; Matthay KK; DuBois SG
Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1396. PubMed ID: 27044383
[No Abstract] [Full Text] [Related]
38. Vesicular monoamine transporter protein expression correlates with clinical features, tumor biology, and MIBG avidity in neuroblastoma: a report from the Children's Oncology Group.
Temple W; Mendelsohn L; Kim GE; Nekritz E; Gustafson WC; Lin L; Giacomini K; Naranjo A; Van Ryn C; Yanik GA; Kreissman SG; Hogarty M; Matthay KK; DuBois SG
Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):474-481. PubMed ID: 26338179
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
